4% hydroquinone versus 4% hydroquinone, 0.05% dexamethasone and 0.05% tretinoin in the treatment of melasma: A comparative study

International Journal of Dermatology

Volumn 44, Issue 7, 2005, Pages 599-601

  Astaneh, Reyhaneh ^a,b   Farboud, Effat ^a,b   Nazemi, Mohammad J ^a,b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROQUINONE; ORAL CONTRACEPTIVE AGENT; RETINOIC ACID; SUNSCREEN;

ARTICLE; CHI SQUARE TEST; CHLOASMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DEPIGMENTATION; DISEASE CLASSIFICATION; DISEASE DURATION; DOUBLE BLIND PROCEDURE; ERYTHEMA; FAMILY HISTORY; HEREDITY; HUMAN; HYPOPIGMENTATION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SKIN MANIFESTATION; SUN EXPOSURE;

ADMINISTRATION, TOPICAL; DERMATOLOGIC AGENTS; DEXAMETHASONE; DRUG COMBINATIONS; HUMANS; HYDROQUINONES; MELANOSIS; TREATMENT OUTCOME; TRETINOIN;

EID: 21844439197     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02246.x     Document Type: Article

References (13)

1. Grimes PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453-1457.
2. Torres JE, Sanchez JL. Melasma and other disorders of hyper pigmentation. In: Arntd KA, Robinson JK, eds. Cutaneous Medicine and Surgery. Philadelphia: W. B. Saunders Co., 1996; 1233-1248.
3. Katasambas A, Antoniou CH. Melasma classification and treatment. J Eur Acad Dermatol Venerol 1995; 4: 217-223.
4. Sánchez JL, Vázquez M. A hydroquinone solution in the treatment of melasma. Int J Dermatol 1982; 21: 55-58.
5. Griffiths CE, Finkle LJ, Ditre CM, et al. Topical tretinoin (retinoic acid) improves melasma: a vehicle-controlled clinical trial. Br J Dermatol 1993; 129: 415-421.
6. Kimbrough-Green CK, Griffiths CE, Finkle LJ, et al. Topical retinoic acid for melasma in black patients. Arch Dermatol 1994; 130: 727-733.
7. Lowe NJ, Rizk D, Grimes P, et al. Azelaic acid 20% cream in the treatment of facial hyper pigmentation in darker-skinned patients. Clinical Therapeutics 1998; 20: 945-959.
8. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol 1975; 111: 40-48.
9. Mills OH, Kligman AM. Further experience with a topical cream for depigmenting human skin. J Soc Cosmet Chem 1978; 29: 147-154.
10. Neering H. Treatment of melasma (chloasma) by local application of a steroid cream. Dermatologica 1975; 151: 349-353.
11. Barry BW, Williams AD. Permeation enhancement through skin. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker Inc., 1995; 468-469.
12. Wilkinsone JB, Moore RJ, eds. Harry's Cosmeticolog, 7th edn. London, UK: Longman Scientific and Technical, 1996; 264-272.
13. Hayakawa R, Ueda H, Nozaki T, et al. Effects of combination treatment with vitamins E and C on chlosma and pigmented contact dermatitis. A double blind controlled clinical trial. Acta Vitaminol Enzymol 1981; 3: 31-38.